CTSS and neoplasm: Ultimately, we showed that the administration of a single dose of a cathepsin S-selective inhibitor LY3000328, which targets both tumor and stromal-supplied cathepsin S, was able to attenuate cancer pain for at least 12 h in two independent xenograft models [16].